Autolus Therapeutics (AUTL) Change in Intangibles (2018 - 2024)
Autolus Therapeutics posted quarterly Change in Intangibles of $12.7 million for Q4 2024, up 60785.71% on a QoQ basis from -$21000.0 in Q2 2018.
Autolus Therapeutics (AUTL) has 2 years of Change in Intangibles data on file, last reported at $12.7 million in Q4 2024.
- For the quarter ending Q4 2024, Change in Intangibles changed N/A year-over-year to $12.7 million; the trailing twelve-month figure through Dec 2025 stood at $12.7 million (changed N/A YoY), and the FY2025 full-year result was $8.1 million, down 36.53% from the prior year.
- Change in Intangibles for Q4 2024 stood at $12.7 million, up from -$21000.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $12.7 million in Q4 2024 and bottomed at $12.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.74 Mn |
| Dec 31, 2024 | 12.74 Mn |
| Jun 30, 2018 | -21,000.00 |
| Jun 30, 2018 | -21,000.00 |